
Article Fingerprint
ReserarchID
MRH9OO2
Choose where you want to hide AI Takeaway. Your site-wide choice will be remembered in this browser.
Kawasaki disease is an acute systemic vasculitis of unknown cause that affects mainly infants and children. Coronary artery lesions (CAL) are one of the most important complications of this disease. An appropriate therapy during acute phase of Kawasaki disease to prevent large CAL has not been established. Recent studies disclosed that aspirin and flurbiprofen appeared to have a negative impact on the suppressive effects of initial intravenous immunoglobulin (IVIG) therapy on CAL development in the acute phase of Kawasaki disease and that an initial single IVIG therapy with delayed administration of anti-inflammatory drugs might be useful for prevention of large CAL. Furthermore, recent study disclosed that variable factors including IVIG resistance, responsiveness, and relapse of disease were associated with CAL complications and that an initial single IVIG therapy may be useful for the prevention of large CAL caused by different factors of Kawasaki disease.
Toshimasa Nakada. 2015. "Usefulness of an Initial Single Intravenous Immunoglobulin Therapy for Kawasaki Disease". Global Journal of Medical Research - F: Diseases GJMR-F Volume 15 (GJMR Volume 15 Issue F4).
Crossref Journal DOI 10.17406/gjmr
Print ISSN 0975-5888
e-ISSN 2249-4618
v1.2
Explore published articles in an immersive Augmented Reality environment. Our platform converts research papers into interactive 3D books, allowing readers to view and interact with content using AR and VR compatible devices.
Your published article is automatically converted into a realistic 3D book. Flip through pages and read research papers in a more engaging and interactive format.
Total Score: 186
Country: Japan
Subject: Global Journal of Medical Research
Authors: Toshimasa Nakada (PhD/Dr. count: 0)
View Count (all-time): 337
Total Views (Real + Logic): 1433
Total Downloads (simulated): 94
Publish Date: 2015 05, Fri
Monthly Totals (Real + Logic):
We use cookies and similar technologies to improve site performance, understand traffic, and enhance your publishing experience. Cookie Policy
Choose which optional cookies Global Journals can use. Your preference applies across this platform and can be updated any time.
These cookies are required for core website functionality and security.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.